Noxopharm Limited
NOXOFOTCHealthcare
$0.05
+$0.00(+0.00%)
Market Cap$14781601
P/E Ratio—
52W High$0.045
52W Low$0.045
Noxopharm Limited (NOXOF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NOXOF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-06 | 2023-06 | 2022-06 | 2021-06 | 2020-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.40M | $6.01M | $5.43M | $5.61M | $8.28M |
| Cost of Revenue | $2.94M | $0.15M | $0.26M | $0.26M | $0.24M |
| Gross Profit | ($0.53M) | $5.86M | $5.17M | $5.35M | $8.04M |
| Gross Margin %(computed) | -22.28% | 97.43% | 95.18% | 95.33% | 97.08% |
| Operating Expenses | |||||
| R&D Expenses | $2.94M | $10.65M | $7.78M | $6.97M | $7.33M |
| G&A Expenses | $1.04M | $4.88M | $6.48M | $6.36M | $6.32M |
| Total Operating Expenses | $7.00M | $16.44M | $14.95M | $14.35M | $16.12M |
| Operating Income | ($7.54M) | ($16.60M) | ($15.21M) | ($14.61M) | ($16.37M) |
| Operating Margin %(computed) | -313.92% | -276.12% | -280.14% | -260.50% | -197.61% |
| Interest Income | $0.01M | $0.08M | $0.05M | $0.14M | $0.01M |
| Interest Expense | $0.03M | $0.04M | $0.08M | $2.20M | $3.47M |
| Income Before Tax | ($3.58M) | ($21.04M) | ($24.03M) | ($8.31M) | ($8.24M) |
| Income Tax Expense | $0.00M | ($5.99M) | ($5.37M) | $1.04M | ($8.33M) |
| Net Income | ($3.58M) | ($15.06M) | ($18.67M) | ($9.35M) | ($0.27M) |
| Net Margin %(computed) | -149.07% | -250.52% | -343.86% | -166.66% | -3.29% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.05 | $-0.06 | $-0.04 | $-0.00 |
| Wtd Avg Shares | 292.26M | 292.24M | 291.22M | 263.85M | 138.36M |
| EBITDA | ($4.60M) | ($14.80M) | ($14.95M) | ($14.35M) | ($7.92M) |
| EBITDA Margin %(computed) | -191.64% | -246.27% | -275.32% | -255.83% | -95.61% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · AUD · M
Explore more Noxopharm Limited data
About Noxopharm Limited (NOXOF) Income Statement
Noxopharm Limited (NOXOF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, NOXOF reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -22.28%), and net income of ($0.00B) — a net profit margin of -149.07%.
Frequently asked questions
NOXOF · 4 questionsNoxopharm Limited (NOXOF) reported revenue of $0.00B for 2024, down 60.1% year-over-year.
NOXOF revenueNOXOF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08